Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization

American Journal of Pathology

Volumn 150, Issue 1, 1997, Pages 81-89

  Plantaz, Dominique ^a,b   Mohapatra, Gayatry ^a   Matthay, Katherine K ^a,c   Pellarin, Malgorzata ^a   Seeger, Robert C ^c,d   Feuerstein, Burt G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c CHILDREN S ONCOLOGY GROUP   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER STAGING; CHROMOSOME 17; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA SEQUENCE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IN SITU HYBRIDIZATION; INFANT; MALE; METAPHASE CHROMOSOME; NEUROBLASTOMA; NUMERICAL CHROMOSOME ABERRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 2; GENE DELETION; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; NEUROBLASTOMA;

EID: 0031031692     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Voute PA, de Kraker J, Hoefnagel CA: Tumors of the sympathetic nervous system: neuroblastoma, ganglloneuroma, and pheochromocytoma. Cancer in Children: Clinical Management, ed 3. Edited by PA Voute, A Barret, J Lemerle. Berlin, Springer-Verlag, 1992, pp 226-243
2. Brodeur GM, Azar C, Brother M, Hiemstra J, Kaufman B, Marshall H, Moley J, Nakagawara A, Saylors R, Scavarda N, Schneider S, Wasson J, White P, Seeger R, Look T, Castleberry R: Neuroblastoma: effect of genetic factors on prognosis and treatment, Cancer 1992, 70:1685-1694
3. Hayashi Y, Kanda N, Inaba T, Hanada R, Nagahara N, Muchi H, Yamamoto K: Cytogenetics findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer, 1989, 63:126-132
4. Christiansen H, Lampert F: Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer 1988, 57:121-126
5. Bourhis J, De Vathaire F, Wilson GD, Hartmann O, Terrier-Lacombe MJ, Boccon-Gibod L, McNally NJ, Lemerle J, Riou G, Bénard J: Combined analysis of DNA ploidy index and NMYC genomic content in neuroblastoma. Cancer Res 1991, 51:33-36
6. Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look T, Brodeur GM: Significance of chromosome 1p loss of heterozygosity in neuroblastoma, Cancer Res 1995, 55:4664-4669
7. Caron H, Van Sluis P, De Kraker J, Bokkerink J, Egeler M, Laureys G, Slater R, Westerweld A, Voute PA, Versteeg R: Allelic loss of chromosomes 1p as a predictor of unfavorable outcome on patients with neuroblastoma. N Engl J Med 1996, 334:225-229
8. Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM: Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 1992, 52:1780-1785
9. Srivatsan ES, Ying KL, Seeger RC: Deletion of chromosome 11 and of 14q sequences in neuroblastoma, Genes Chromosomes & Cancer 1993, 7:32-37
10. Takayama H, Suzuki T, Mugishima H, Fujisawa T, Ookuni M, Schwab M, Gehring M, Nakamura Y, Sugimura T, Terada M: Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Oncogene 1992, 7:1185-1189
11. Gilbert F, Feder M, BalabanG, Brangman D, Lurie DK, Podolsky R, Rinaidt V, Vinikoor N, Weisband J: Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 1984, 44:5444-5449
12. Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, Nakamura Y, Kaneko Y: There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes & Cancer 1994, 10:30-39
13. Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM, Magdelenat H, Thomas G, Delattre O: Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes & Cancer 1994, 10:275-281
14. Caron H, Peter M, Van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugières L, Voûte PA, Westerveld A, et al: Evidence for two tumour suppressor loci on chromosomal bands 1 p35-36 involved in neuroblastoma: one probably imprinted, another associated with NMYC amplification. Hum Mol Genet 1995, 4:535-539
15. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J: Amplified DMA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 1983, 305:245-248
16. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM: Amplification of NMYC in untreated human neuroblastomas correlates with advanced disease stage, Science 1984, 224:1121-1124
17. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D: Association of multiple copies of the NMYC oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313:1111-1116
18. Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM: Clinical relevance of tumor cell ploidy and NMYC gene amplification in childhood neuroblastoma; a Pediatrie Oncology Group study. J Clin Oncol 1991, 9:581-591
19. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-821
20. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes & Cancer 1994, 10:231-243
21. Mohapatra G, Kim DH, Feuerstein BG: Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes Chromosomes & Cancer 1995, 13:86-93
22. Piper J, Rutovitz D, Sudar D, Kallioniemi A, Kallioniemi OP, Waldman FM, Gray JW, Pinkel D: Computer image analysis of comparative genomic hybridization. Cytometry 1995, 19:10-26
23. Mitelman F (Ed): Catalog of Chromosomes Aberrations in Cancer, ed 5. Edited by F Mitelman. New York, Wiley-Liss, 1994
24. Shapiro DN, Valentine MB, Rowe ST, Sinclair AE, Sublett JE, Roberts WM, Look AT: Detection of N-myc gene amplification by fluorescence in situ hybridization: diagnostic utility for neuroblastoma. Am J Pathol 1993, 142:1339-1346
25. Brodeur GM, Sekhon GS, Goldstein MM: Chromosomal aberrations in human neuroblastomas. Cancer 1977, 40:2277-2283
26. Gilbert F, Feder M, Balaban G, Brangman D, Lurie DK, Podolsky R, Rinaldt V, Vinikoor N, Weisband J: Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 1984, 44:5444-5449
27. Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL, Tsiatis AA: Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 1981, 41:4678-4686
28. Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR, Hanash SM: High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 1991, 88:341-345
29. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ, Steeg PS: Evidence for nm23 RNA overexpression, DMA amplification. and mutation in aggressive childhood neuroblastomas. Oncogene 1993, 8:855-865
30. Laureys G, Speleman F, Opdenakker G, Benoit Y, Leroy J: Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma. Genes Chromosomes & Cancer 1990, 3:252-254
31. Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R, Speleman F: 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes & Cancer 1994, 2:103-114
32. Savelyeva L, Corvi R, Schwab M: Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 1994, 55:334-340
33. Bader SA, Fasching C, Brodeur GM, Stanbridge EJ: Dissociation of suppression of tumorigenicity and differentiation In vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 1991, 2:245-255
34. Mertens F, Johansson B, Mitelman F: Isochromosomes in neoplasia. Genes Chromosomes & Cancer 1994, 10:221-230
35. McDonald JD, Daneshvar L, Willert JR, Matsumura K, Waldman F, Cogen PH: Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 1994, 23:229-232
36. Vogan K, Bernstein M, Leclerc JM, Brisson L, Brossard J, Brodeur GM, Pelletier J, Gros P: Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 1993, 53:5269-5273.